This content is machine translated Oncology Multidisciplinary and cross-indication – the latest trends The central task of the European Society for Medical Oncology (ESMO) is to improve the quality of cancer treatment, cancer prevention and diagnosis as well as palliative care and aftercare…
View Post 3 min This content is machine translated Advanced pancreatic cancer First-line therapies in the Real Life Check Currently, gemcitabine plus Nab-paclitaxel and FOLFIRINOX are considered standard first-line therapies for advanced pancreatic cancer. So far, there is no direct comparison of these options. An analysis of the German…
View Post 2 min This content is machine translated Pancreatic Cancer Effectiveness of treatment depends on molecular prerequisites Pancreatic cancer is one of the greatest challenges in oncologic therapy. Mortality is extremely high despite intensive research. New treatment options are urgently needed. A team of researchers has now…
View Post 11 min This content is machine translated Developments in pancreatic cancer Pancreatic cancer – still particularly aggressive and deadly Pancreatic cancer is the seventh most common cancer diagnosis in Switzerland. However, it ranks fourth in terms of mortality, which illustrates the aggressiveness of the tumor. Various studies, especially in…
